Status: Phase 2
Entry Type: Unknown
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Burkitt Lymphoma; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Lymphoid; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Lymphoma; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Myelodysplastic Syndromes; Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Waldenstrom Macroglobulinemia Phase 1/Phase 2 ClinicalTrials
Disease; Metabolic Diseases Phase 2 ClinicalTrials
Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Lymphoid; Multiple Myeloma; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma Phase 2 ClinicalTrials
CONTENTS